U.S. market Closed. Opens in 1 day 32 minutes

RPTX | Repare Therapeutics Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue51.13M131.83M7.60M135.00KN/AN/AN/A
Cost of Revenue131.20M4.18M3.34M1.79M968.00K407.00K102.00K
Gross Profit-80.07M127.65M4.26M-1.65M-968.00K-407.00K-102.00K
Operating Expenses167.36M151.63M116.26M54.44M26.38M12.82M6.17M
Selling, General & Admin33.76M32.56M26.21M14.35M5.38M2.91M1.77M
Research & Development133.59M119.07M90.05M40.09M21.00M9.91M4.40M
Other Operating ExpensesN/A-43.00K-41.00K-16.00K-1.36M-1.14M-1.47M
Operating Income-116.22M-19.80M-108.66M-54.30M-26.38M-12.82M-6.17M
Other Expenses / Income13.04M5.90M74.00K-440.00K-644.00K-1.43M-1.62M
Before Tax Income-103.18M-13.90M-108.59M-54.74M-27.02M-14.25M-7.80M
Income Tax Expenses-9.38M15.15M-1.68M-1.32M195.00K35.00K147.00K
Net Income-93.80M-29.05M-106.91M-53.42M-27.22M-14.28M-7.80M
Interest ExpensesN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding42.09M41.92M37.82M36.90M36.67M15.79M15.79M
Diluted Shares Outstanding42.09M41.92M37.82M36.90M36.67M15.79M15.79M
EBITDA-114.27M-17.82M-107.19M-53.41M-25.49M-13.51M-7.53M
EBITDA Margin-223.48%-13.52%-1,410.38%-39,559.26%0.00%0.00%0.00%
EBIT-103.18M-13.90M-108.59M-54.74M-27.02M-14.25M-7.65M
EBIT Margin-201.79%-10.54%-1,428.76%-40,549.63%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙